The Road Ahead: Expert Perspectives on Recent Therapeutic Advances in Small-Cell Lung Cancer

Get up to date on the optimal treatment of extensive-stage SCLC with this expert-led educational program featuring a ClinicalThought commentary on what’s new going into 2024 and 2 CME-certified text modules with downloadable slidesets capturing the standard of care and what’s on the horizon.

Share

Program Content

Activities

Tx Advances SCLC Module
Recent Therapeutic Advances in Advanced SCLC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: March 26, 2024

Expires: March 25, 2025

SoC Tx Advanced SCLC Module
Standard-of-Care Therapy in Advanced SCLC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: March 29, 2024

Expires: March 28, 2025

Activities

SoC Tx Advanced SCLC Slides
Standard of Care Therapy in Advanced SCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 22, 2024

Expires: March 21, 2025

Tx Advances SCLC Slides
Recent Therapeutic Advances in Advanced SCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 25, 2024

Expires: March 24, 2025

Activities

New Tx for Relapsed SCLC
What’s New in the Treatment of Relapsed SCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: January 22, 2024

Faculty

cover img faculity

Carl M. Gay, MD, PhD

Assistant Professor
Department of Thoracic/Head & Neck Oncology
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Mark A. Socinski, MD

Executive Medical Director
AdventHealth Cancer Institute
Orlando, Florida

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Amgen and AstraZeneca Pharmaceuticals.

Amgen

AstraZeneca Pharmaceuticals